Disclosures for "SCN1A-associated Episodic Encephalopathy in a School-aged Child: A Phenotypic Overlap with Familial Hemiplegic Migraine?"
-
Dr. Yao has nothing to disclose.
-
Dr. Kuerbitz has nothing to disclose.
-
Dr. Mizerik has nothing to disclose.
-
Dr. Gonzalez has nothing to disclose.
-
Dr. Cheong has nothing to disclose.
-
Dr. Cheek has nothing to disclose.
-
Dr. Holder has received personal compensation in the range of $0-$499 for serving as a Consultant with Stoke Pharmaceutical.
-
The institution of Dr. Clark has received research support from Greewich pharmaceuticals. The institution of Dr. Clark has received research support from Novartis.
-
Dr. Hull has received publishing royalties from a publication relating to health care.